CEACAM1 and myeloid sarcoma: To collect evidence for the presence of CEACAM1+ B cells in the CNS of MS patients, we used post mortem brain sections from n = 12 MS patients (Supplementary Table 5), which contained lymphocytic infiltration (Fig. 4A) for IHC.